Tabriz, Iran: The consumption of hemp seed nutritional oil, in conjunction with the intake of evening primrose oils and a restricted diet high in hot-natured foods (such as pepper) and low in saturated fats and sugars, is associated with “significant improvement” in symptom management and immunological characteristics in subjects with multiple sclerosis (MS), according to clinical trial data published in the current issue of the scientific journal BioImpacts.
Researchers at the Tabriz University of Medical Sciences in Iran assessed the impact of hemp seed oil, evening primrose oils, and a restricted diet in 23 patients diagnosed with relapsing remitting MS. They reported that participants at the study’s completion “were healthier in comparison to baseline” and that “clinical and immunological parameters showed improvement in the patients after the intervention.” Authors acknowledged that hemp seed oil possesses potent antioxidative properties and also likely acts on specific signaling pathways that regulate inflammatory responses – two characteristics that would presumably make it beneficial in the treatment of MS.
Authors concluded: “After six months, significant improvements in extended disability status score were found. … Our data demonstrated that co-supplemented hemp seed and evening primrose oils with hot-natured diet intervention may decrease the risk of developing MS.”
Previously published clinical trials assessing the impact of inhaled cannabis and extracted organic cannabinoids in patients with MS have demonstrated that plant cannabinoids can alleviate disease symptoms – such as involuntary spasticity, neuropathy, and bladder dysfunction – and, in some subjects, may actually moderate disease progression. Nonetheless, the National MS Society shares little enthusiasm for the therapeutic use of either cannabis or cannabis-derived products as a treatment option for MS patients, stating on its website: “[B]ased on the studies to date – and the fact that long-term use of marijuana may be associated with significant, serious side effects – it is the opinion of the National Multiple Sclerosis Society’s Medical Advisory Board that there are currently insufficient data to recommend marijuana or its derivatives as a treatment for MS symptoms.”